Molecular Partners Confirms Ultra-Potent Inhibition of SARS-CoV-2 Live Virus by Anti-COVID-19 DARPin® Candidates
DARPin® antiviral candidates demonstrate low picomolar potency in live virus assay Candidate construction complete; two candidates ready for preclinical development & manufacturing Therapeutic profile of a highly potent antiviral biologic with a long half-life supports both a prophylactic and therapeutic approach [...]